Fujita N, Fujita K, Kim SJ, Iguchi C, et al. Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-up of Prognostic Study Using Propensity Score Matching. Oncology 2022 Feb 3. pii: 000522384. doi: 10.1159/000522384.
PMID: 35114682